No Right to Sublicense. Each Licensee hereby expressly agrees not to sublicense the Licenses to any Person without the express prior written consent of Licensor.
No Right to Sublicense. You shall not assign or sublicense any rights granted under this Agreement to use the Product to any other person or party.
No Right to Sublicense. Customer shall not have any right to sublicense the rights granted herein or use the Software in a service bureau capacity or any other manner except as expressly authorized in this Agreement.
No Right to Sublicense. Subject to Section 9.1, rights granted to Licensee by this Agreement are personal to Licensee alone. Licensee shall have no right to sublicense, assign or otherwise transfer or, subject to Section 2.3, share its rights hereunder.
No Right to Sublicense. The JV shall not sublicense any of its rights under the License Agreement; except that, the JV will be permitted to sublicense any of its rights under the License Agreement to subsidiaries of the JV. BOARD OF THE JV The Board will at all times consist of four directors (each, a“Director”). ID&T will be entitled to appoint two Directors (“ID&T Directors”) and SFX will be entitled to appoint two Directors (“SFX Directors”), each appointment and any appointment of a replacement Director being subject to the other Party’s reasonable consent. Directors can be removed only by the Party appointing such Director. No person will be permitted to take an affirmative action on behalf of the JV unless the Board has authorized (either generally or specifically) such action; provided that the Board shall be deemed to have granted each of the Co-CEOs the authorizations described below. The Board must authorize the JV to promote at least six Events annually, four of which must use the “Sensation” Brand, one of which must use the “Mysteryland” Brand and one of which must use the “Defqonl” Brand, it being understood that the SFX-designated Board members will be deemed to have satisfied this obligation with respect to any Event that such members vote to authorize. Among other things, the Board will meet to determine the JV’s annual budget and strategic and operating plan. If there is a tie in the voting of the Board with respect to any matter, the matter shall be directed to the senior executives of the JV Members, who shall seek to unanimously resolve the matter and, if such senior executives are unable to resolve the matter, then either party is permitted to refer such matter to Binding Arbitration to be resolved. MANAGEMENT AND OPERATION OF THE JV The JV will be managed on a day-to-day basis by its officers, which may be the same persons as the Directors. One Co-CEO and the CFO of the JV will be appointed by SFX. Xxxxxxx Xxxxxx (“Xxxxxx”) will serve initially as the JV’s Co-CEO appointed by SFX. If Xxxxxx resigns from, is removed from, or otherwise no longer serves in his position as a Co-CEO, then SFX will be entitled to appoint a replacement Co-CEO, but only if such appointee is reasonably acceptable to ID&T. It is agreed that ID&T may withhold such approval if the replacement Co-CEO is a competitor of ID&T, ID&T has had prior dealings with such person that were unsatisfactory to ID&T or if ID&T perceives that such person may have a conflict of interest, including due to...
No Right to Sublicense. Except as set forth in Sections 2.1(b), 2.1(d) and 2.1(e) of the Master License and subject to Section 2.1(g) thereof, (i) Licensee is not granted any right to sublicense the Licensed Materials to any Person, and (ii) Licensee covenants and agrees that it shall not sublicense the Licensed Materials to any Person.
No Right to Sublicense. The licenses granted under this Section 5.1 shall not include the right to grant or authorize sublicenses; provided however that the use by a Party of subcontractors shall not be construed as a sublicense.
No Right to Sublicense. Licensee shall have no right to sublicense the Licensed Property to any third party without the express prior written consent of Licensor, which consent may be withheld at Licensor's discretion for any reason.
No Right to Sublicense. The Company shall not have the right to sublicense to others any of the rights that have been granted under ARTICLE II hereof.
No Right to Sublicense. OSI shall not have the right to sublicense its rights hereunder. During the term of this Agreement, OSI may practice the CADUS Technology and CADUS Patents in connection with assay development and screening for Third Parties pursuant to collaborative research programs with such Third Parties ("Third Party Collaborators"), provided that such assay development and screening takes place at OSI's facilities and is conducted by OSI personnel. In addition, a Third Party Collaborator may utilize assays developed by OSI using CADUS Technology to test compounds solely during the term and in furtherance of its collaboration with OSI.
